BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia
- OPACC
- Jul 7, 2023
- 1 min read
BDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute lymphoblastic leukemia.
Comentários